|Bid||257.22 x 800|
|Ask||257.47 x 800|
|Day's Range||256.42 - 259.75|
|52 Week Range||208.48 - 287.94|
|Beta (3Y Monthly)||0.88|
|PE Ratio (TTM)||20.21|
|Earnings Date||Jan 14, 2019 - Jan 18, 2019|
|Forward Dividend & Yield||3.60 (1.36%)|
|1y Target Est||309.41|
Catalyst Health Network (Catalyst) and UnitedHealthcare’s accountable care organization (ACO) has improved the number of annual preventive screenings year over year for cervical cancer, breast cancer and colorectal cancer, and lowered health care costs in North Texas by more than $28 million in the last two years.
Wall Street's major indexes all slid more than 2 percent on Monday, with the benchmark S&P 500 closing at its lowest in 14 months, on concerns about slowing economic growth ahead of a highly anticipated decision from the Federal Reserve this week on the course of U.S. interest-rate hikes. The S&P 500 hit its lowest since October 2017 to breach lows reached during its sell-off in February, having wiped out about $3.4 trillion of market value since late September.
BlackBerry (BB) is likely to report lower year-over-year revenues in the fiscal third quarter, primarily due to negative impact of the changes in the accounting and sales model.
Minnetonka-based UnitedHealth and DaVita agreed to drop the purchase price from $4.9 billion to $4.34 billion.
Shares of Johnson & Johnson (NYSE:JNJ) have fallen below their 200-day moving average to return to levels not seen since August, down nearly 13% from the highs seen in early December. Analysts are looking for earnings of $1.95 per share on revenues of $20.2 billion. Gilead Sciences (NASDAQ:GILD) shares are down 16% from the highs set in early October, a double-top high that now sets up a possible violation of the May lows that would put the mid-2017 levels near $60 in play — which would be worth a 10% drop from current levels.
Stock market Monday: Hospital stocks were reacting to a federal judge's ruling Friday in Texas on ObamaCare. Judge Reed O'Connor ruled the entirety of the ObamaCare law unconstitutional.
Boeing strikes a deal, Goldman, Centene and HCA Health dive as today's stock market opens, and investors look toward a rate hike decision from the Fed.
Throwing out ACA as healthcare law in the U.S. would create plenty of tremors within the healthcare industry -- to say nothing of Insurance, Pharmaceuticals and related business sectors.
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Moody's Investors Service has assigned an A3 senior unsecured debt rating to UnitedHealth Group's (UnitedHealth, NYSE: UNH, senior debt at A3) planned issuance of approximately $2.5 billion of senior unsecured debt due in February 2024, and December 2025, 2028 and 2048. Net proceeds from the offering are general corporate purposes, including the refinancing of commercial paper (approximately $20 million outstanding as of September 30, 2018), the repayment of approximately $750 million outstanding 1.700% notes due February 15, 2019, the repayment of approximately $500 million outstanding 1.625% notes due March 15.
In the latest trading session, UnitedHealth Group (UNH) closed at $270.64, marking a +1.28% move from the previous day.
The latest on developments in financial markets (all times local): 4 p.m. Stocks ended higher as traders keep up hope that the U.S. and China will make progress on resolving their trade dispute. Technology ...
were some of the most-held names by U.S. hedge funds in the third quarter, according to a list compiled by WalletHub. 1. Microsoft has risen 26.95% year to date. It's the company's cloud business that continues to have the brightest outlook, David Miller, chief investment officer of Catalyst Funds told TheStreet.
The nation’s obesity rate has reached the highest-ever level this year, according to the United Health Foundation’s 2018 America’s Health Rankings® Annual Report. Obesity is a leading contributor to cardiovascular disease, cancer and other conditions. Additionally, an increase in drug deaths, suicides and cardiovascular disease deaths is contributing to an increase in premature death.
After serving as CEO for Mayo Clinic in Arizona for eight years, Dr. Wyatt Decker is retiring, briefly, before moving on to a new job. "I've been in the job eight years now," Decker said. "That's a good run for a CEO." He was approached by Optum Healthcare, which is part of Minnesota-based UnitedHealth Group Inc. (NYSE: UNH), to take a senior executive role.
After almost a year of lawsuits, op-eds and accusations of over-billing and “tactics that fuel conflict,” Nashville-based Envision Healthcare and UnitedHealthcare have reached a compromise. On Tuesday, the two companies announced they have agreed to a contract extension that will allow the Minneapolis-based health insurer to cover services from Envision physicians, according to a news release. Nashville-based Envision was the city’s third-largest publicly traded health care company, with $7.8 billion of revenue in 2017, before it was sold to private-equity firm KKR for $9.9 billion earlier this year.
After hitting records in September, the S&P 500 has lost all gains for the year to hold just under the flat line. Ari Wald, head of technical analysis at Oppenheimer, said one corner of the market still works in both good times and bad. The S&P 500's managed health-care sub-industry has surged so far this year.
Simply put, the stocks that were leading the broad market higher as recently as September suffered a painful about-face when October's correction came knocking. One of the stocks that's working right now is UnitedHealth Group Inc. The uptrend in UnitedHealth has been pretty unmistakable this year.